Valuation: Balchem Corporation

Market Cap 572.62Cr 490.51Cr 458.96Cr 420.12Cr 788.45Cr 55TCr 798.87Cr 5.42TCr 2.11TCr 28TCr 2.15TCr 2.1TCr 91TCr P/E 2026 *
33.2x
P/E 2027 * 31.9x
Enterprise Value 576.18Cr 493.55Cr 461.81Cr 422.73Cr 793.34Cr 55TCr 803.82Cr 5.46TCr 2.13TCr 28TCr 2.16TCr 2.12TCr 92TCr EV / Sales 2026 *
5.09x
EV / Sales 2027 * 4.76x
Free-Float
99.53%
Yield 2026 *
0.65%
Yield 2027 * 0.73%
1 day+0.79%
1 week+1.10%
Current month+7.71%
1 month+12.02%
3 months+11.58%
6 months+2.73%
Current year+17.68%
1 week 176.54
Extreme 176.54
182
1 month 159.91
Extreme 159.91
182.06
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 65.37
Extreme 65.37
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap.
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

General Counsel

11,315 0.0349%
Change 5-day change 1-year change 3-year change Capi.($)
+0.79%+1.10%+11.45%+33.22% 572.62Cr
-0.45%+1.45%-1.05%+55.21% 7.89TCr
+1.01%-2.65%-1.51%-24.13% 3.69TCr
+0.21%-0.15%-4.28%+19.20% 3.77TCr
-0.09%-1.83%-9.74%+18.71% 2.42TCr
+0.84%-2.76%+25.44%+19.00% 2.25TCr
+4.37%+10.00%+80.66%+25.89% 2.24TCr
+0.31%-5.02%-37.89%-38.09% 1.87TCr
+6.57%+4.40%+80.06%-24.42% 1.58TCr
-0.73%-3.86%+3.99%+76.23% 1.44TCr
Average +1.38%-0.08%+14.72%+16.08% 2.77TCr
Weighted average by Cap. +0.95%+0.10%+9.11%+21.05%

Financials

2026 *2027 *
Net sales 113.16Cr 97Cr 91Cr 83Cr 155.82Cr 11TCr 157.87Cr 1.07TCr 417.89Cr 5.44TCr 424.92Cr 415.67Cr 18TCr 119.58Cr 102.43Cr 96Cr 88Cr 164.65Cr 11TCr 166.82Cr 1.13TCr 441.58Cr 5.75TCr 449Cr 439.23Cr 19TCr
Net income 17Cr 15Cr 14Cr 13Cr 24Cr 1.67TCr 24Cr 165.57Cr 65Cr 840.4Cr 66Cr 64Cr 2.78TCr 18Cr 16Cr 15Cr 13Cr 25Cr 1.74TCr 25Cr 172.56Cr 67Cr 875.87Cr 68Cr 67Cr 2.9TCr
Net Debt 3.55Cr 3.04Cr 2.85Cr 2.61Cr 4.89Cr 339.78Cr 4.95Cr 34Cr 13Cr 170.69Cr 13Cr 13Cr 564.56Cr -3.97Cr -3.4Cr -3.18Cr -2.91Cr -5.46Cr -379.64Cr -5.54Cr -38Cr -15Cr -190.71Cr -15Cr -15Cr -630.79Cr
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
22/26/22 $180.48 +0.47% 79,941
20/26/20 $179.63 -0.31% 1,39,606
19/26/19 $180.19 +1.80% 1,31,055
18/26/18 $177.00 -0.77% 1,69,671
17/26/17 $178.38 -0.07% 1,08,621
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
179.63USD
Average target price
209.25USD
Spread / Average Target
+16.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock